参考文献/References:
[1] The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.Tissue plasminogen activator for acute ischemic stroke[J].N Engl J Med,1995,333(24):1581-1587.
[2] Hacke W,Kaste M,Bluhmki E,et al.Thrombolysis with alteplase 3 to 4[J].5 hours after acute ischemic stroke.N Engl J Med,2008,359(13):1317-1329.
[3] Gao Y,Churilov L,Teo S,et al.Remote intracerebral haemorrhage post intravenous thrombolysis: Experience from an Australian stroke centre[J].Journal of Clinical Neuroscience,2015,22(2):352-356.
[4] Turner RJ,Sharp FR.Implications of MMP9 for blood brain barrier disruption and hemorrhagic transformation following ischemic stroke[J].Front Cell Neurosci,2016,10:56.
[5] Jickling GC,Liu DZ,Stamova B,et al.Hemorrhagic transformation after ischemic stroke in animals and humans[J].Journal of Cerebral Blood Flow and Metabolism,2014,34(2):185-199.
[6] Hafez S,Abdelsaid M,El-Shafey S,et al.Matrix metalloprotease 3 exacerbates hemorrhagic transformation and worsens functional outcomes in hyperglycemic stroke[J].Stroke,2016,47(3):843-851.
[7] Vandelli L,Marietta M,Gambini MA,et al.Fibrinogen decrease after intravenous thrombolysis in ischemic stroke patients is a risk factor for intracerebral hemorrhage[J].Journal of Stroke & Cerebrovascular Diseases,2015,24(2):394-400.
[8] Sun XH,Berthiller J,Trouillas P,et al.Early fibrinogen degradation coagulopathy: A predictive factor of parenchymal hematomas in cerebral rt-PA thrombolysis[J].J Neurol Sci,2015,351(1/2):109-114.
[9] Tuo YH,Liu Z,Chen JW,et al.NADPH oxidase inhibitor improves outcome of mechanical reperfusion by suppressing hemorrhagic transformation[J].J Neurointerv Surg,2016,9(5):492-498.
[10] Ritzel RM,Lai YJ,Crapser JD,et al.Aging alters the immunological response to ischemic stroke[J].Acta Neuropathol,2018,136(1):89-110.
[11] Da SA, Argibay B, Iglesias-Rey R, et al. Vectorizednanodelivery systems for ischemic stroke: A concept and a need[J]. J Nanobiotechnology, 2017, 15(1): 30.
[12] Kanazawa M,Takahashi T,Nishizawa MA.Therapeutic strategies to attenuate hemorrhagic transformation after tissue plasminogen activator treatment for acute ischemic stroke[J].J Atheroscler Thromb,2017,24(3):240-253.
[13] Wu L,Ye Z,Pan Y,et al.Vascular endothelial growth factor aggravates cerebral ischemia and reperfusion-induced blood-brain-barrier disruption through regulating LOC102640519/HOXC13/ZO-1 signaling[J].Exp Cell Res,2018,369(2):275-283.
[14] Nag S,Manias JL,Kapadia A,et al.Molecular changes associated with the protective effects of angiopoietin-1 during Blood-Brain barrier breakdown Post-Injury[J].Mol Neurobiol,2017,54(6):4232-4242.
[15] Iadecola C,Anrather J.The immunology of stroke: from mechanisms to translation[J].Nat Med,2011,17(7):796-808.
[16] Dhaya I,Griton M,Raffard G,et al.Bacterial lipopolysaccharide-induced systemic inflammation alters perfusion of white matter-rich regions without altering flow in brain-irrigating arteries: Relationship to blood-brain barrier breakdown?[J].J Neuroimmunol,2018,314:67-80.
[17] Chi LM,Huang YJ,Mao Y,et al.Tail vein infusion of Adipose-Derived mesenchymal stem cell alleviated inflammatory response and improved blood brain barrier condition by suppressing endoplasmic reticulum stress in a middle cerebral artery occlusion rat model[J].Medical Science Monitor,2018,24:3946-3957.
[18] Paciaroni M,Agnelli G,Falocci N,et al.Early recurrence and cerebral bleeding in patients with acute ischemic stroke and atrial fibrillation: effect of anticoagulation and its timing: the RAF study[J].Stroke,2015,46(8):2175-2182.
[19] Tisserand M,Turc G,Charron S,et al.Does diffusion lesion volume above 70 mL preclude favorable outcome despite Post-Thrombolysis recanalization?[J].Stroke,2016,47(4):1005-1011.
[20] Acampa M,Camarri S,Lazzerini PE,et al.Increased arterial stiffness is an Independent risk factor for hemorrhagic transformation in ischemic stroke undergoing thrombolysis[J].Int J Cardiol,2017,243:466-470.
[21] Liu KQ,Yan SQ,Zhang S,et al.Systolic blood pressure variability is associated with severe hemorrhagic transformation in the early stage after thrombolysis[J].Transl Stroke Res,2016,7(3):186-191.
[22] Hu Q,Manaenko A,Bian H,et al.Hyperbaric Oxygen reduces infarction volume and hemorrhagic transformation through ATP/NAD(+)/Sirt1 pathway in hyperglycemic middle cerebral artery occlusion rats[J].Stroke,2017,48(6):1655-1664.
[23] Snarska KK,Bachórzewska-Gajewska H,Kapica-Topczewska K,et al.Hyperglycemia and diabetes have different impacts on outcome of ischemic and hemorrhagic stroke[J].Arch Med Sci,2017,13(1):100-108.
[24] Chen GJ,Wang AX,Zhao XQ,et al.Frequency and risk factors of spontaneous hemorrhagic transformation following ischemic stroke on the initial brain CT or MRI: data from the China National Stroke Registry(CNSR)[J].Neurol Res,2016,38(6, SI):538-544.
[25] Marsh EB,Llinas RH,Schneider AL,et al.Predicting hemorrhagic transformation of acute ischemic stroke prospective validation of the HeRS score[J].Medicine(Baltimore),2016,95(2):e2430.
[26] Kwon I,An S,Kim J,et al.Hemorrhagic transformation after large cerebral infarction in rats pretreated with dabigatran or warfarin[J].Stroke,2017,48(10):2865-2871.
[27] Lin Q,Li Z,Wei R,et al.Increased risk of Post-Thrombolysis intracranial hemorrhage in acute ischemic stroke patients with leukoaraiosis: a Meta-Analysis[J].PLoS One,2016,11(4):e0153486.
[28] Dey AK,Stamenova V,Turner G,et al.Pathoconnectomics of cognitive impairment in small vessel disease: A systematic review[J].Alzheimers & Dementia,2016,12(7):831-845.
[29] Whiteley WN,Slot KB,Fernandes P,et al.Risk factors for intracranial hemorrhage in acute ischemic stroke patients treated with recombinant tissue plasminogen activator: a systematic review and meta-analysis of 55 studies[J].Stroke,2012,43(11):2904-2909.
[30] Yingqi,Xing,Zhen ZN,et al.Increased globulin and its association with hemorrhagic transformation in patients receiving intra-arterial thrombolysis therapy[J].Neurosci Bull,2014,30(3):469-476.
[31] Che RW,Huang XQ,Zhao WB,et al.Low serum albumin level as a predictor of hemorrhage transformation after intravenous thrombolysis in ischemic stroke patients[J].Sci Rep,2017,7(1):7776.
[32] Seo JH,Maki T,Maeda M,et al.Oligodendrocyte precursor cells support blood-brain barrier integrity via TGF-β signaling[J].PLoS One,2014,9(7):e103174.
[33] Cai YY,Liu XF,Chen WX,et al.TGF-beta 1 prevents blood-brain barrier damage and hemorrhagic transformation after thrombolysis in rats[J].Exp Neurol,2015,266:120-126.
[34] Álvarez-Sabín J,Maisterra O,Santamarina E,et al.Factors influencing haemorrhagic transformation in ischaemic stroke[J].Lancet Neurol,2013,12(7):689-705.
[35] Karaszewski B,Houlden H,Smith EE,et al.What causes intracerebral bleeding after thrombolysis for acute ischaemic stroke? Recent insights into mechanisms and potential biomarkers[J].J Neurol Neurosurg Psychiatry,2015,86(10):1127-1136.
[36] Mallolas J,Rodríguez R,Gubern C,et al.A polymorphism in the promoter region of the survivin gene is related to hemorrhagic transformation in patients with acute ischemic stroke[J].Neuromolecular Med,2014,16(4):856-861.
[37] Zhang XM,Cao XH,Xu XY,et al.Correlation between the-1562C/T polymorphism in the matrix metalloproteinase-9 gene and hemorrhagic transformation of ischemic stroke[J].Exp Ther Med,2015,9(3):1043-1047.
[38] Jickling GC,Ander BP,Stamova B,et al.RNA in blood is altered prior to hemorrhagic transformation in ischemic stroke[J].Ann Neurol,2013,74(2):232-240.
[39] Mehta RH,Cox M,Smith EE,et al.Race/ethnic differences in the risk of hemorrhagic complications among patients with ischemic stroke receiving thrombolytic therapy[J].Stroke,2014,45(8):2263-2269.
[40] Díaz-Maroto C,Fernández-Díaz E,García-García J,et al.The UCP2-866G/A polymorphism could be considered as a genetic marker of different functional prognosis in ischemic stroke after recanalization[J].Neuromolecular Med,2017,19(4):571-578.
[41] Diaz-Canestro C,Merlini M,Bonetti NR,et al.Sirtuin 5 as a novel target to blunt blood-brain barrier damage induced by cerebral ischemia/reperfusion injury[J].Int J Cardiol,2018,260:148-155.
[42] Zhou YF,Li YN,Jin HJ,et al.Sema4D/PlexinB1 inhibition ameliorates blood-brain barrier damage and improves outcome after stroke in rats[J].FASEB Journal,2018,32(4):2181-2196.
[43] Merino-Zamorano C,Hernández-Guillamon M,Jullienne A,et al.NURR1 involvement in recombinant tissue-type plasminogen activator treatment complications after ischemic stroke[J].Stroke,2015,46(2):477-484.
[44] Kanazawa M, Kawamura K, Takahashi T, et al. Progranulin. Nihon Rinsho, 2016, 74(4): 579-582.
[45] Liu Z,Tuo YH,Chen JW,et al.NADPH oxidase inhibitor regulates microRNAs with improved outcome after mechanical reperfusion[J].J Neurointerv Surg,2017,9(7):702-706.